BDF Gestion Buys Shares of 12,508 Cencora, Inc. $COR

BDF Gestion purchased a new position in shares of Cencora, Inc. (NYSE:COR) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 12,508 shares of the company’s stock, valued at approximately $3,909,000.

A number of other large investors have also made changes to their positions in COR. Norges Bank purchased a new stake in Cencora during the second quarter worth about $695,215,000. Artisan Partners Limited Partnership acquired a new stake in shares of Cencora during the 2nd quarter valued at approximately $411,888,000. Vanguard Group Inc. boosted its stake in shares of Cencora by 5.3% during the 2nd quarter. Vanguard Group Inc. now owns 22,479,041 shares of the company’s stock worth $6,740,340,000 after acquiring an additional 1,125,661 shares in the last quarter. Viking Global Investors LP grew its holdings in shares of Cencora by 95.0% in the 2nd quarter. Viking Global Investors LP now owns 2,081,732 shares of the company’s stock worth $624,207,000 after acquiring an additional 1,013,913 shares during the period. Finally, Ameriprise Financial Inc. boosted its position in Cencora by 228.6% during the second quarter. Ameriprise Financial Inc. now owns 974,505 shares of the company’s stock worth $292,207,000 after purchasing an additional 677,952 shares in the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Wall Street Analysts Forecast Growth

COR has been the subject of several research reports. JPMorgan Chase & Co. lifted their price target on Cencora from $344.00 to $417.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 11th. Evercore ISI set a $400.00 price target on shares of Cencora and gave the company an “outperform” rating in a report on Thursday, November 6th. Robert W. Baird set a $392.00 price objective on shares of Cencora in a research note on Tuesday. Wells Fargo & Company lifted their price objective on Cencora from $354.00 to $405.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 11th. Finally, TD Cowen increased their target price on Cencora from $350.00 to $400.00 and gave the company a “buy” rating in a report on Monday, November 10th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, Cencora presently has an average rating of “Moderate Buy” and an average price target of $373.25.

Insider Activity at Cencora

In other news, CEO Robert P. Mauch sold 5,097 shares of the stock in a transaction dated Monday, October 20th. The shares were sold at an average price of $326.80, for a total transaction of $1,665,699.60. Following the transaction, the chief executive officer directly owned 37,940 shares in the company, valued at $12,398,792. This represents a 11.84% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 10.80% of the stock is currently owned by corporate insiders.

Cencora Stock Up 0.1%

Shares of NYSE COR opened at $341.07 on Friday. The firm has a market cap of $66.16 billion, a P/E ratio of 42.90, a price-to-earnings-growth ratio of 1.62 and a beta of 0.63. The company has a debt-to-equity ratio of 4.32, a quick ratio of 0.55 and a current ratio of 0.90. Cencora, Inc. has a 1 year low of $223.92 and a 1 year high of $377.54. The firm’s 50 day moving average price is $346.49 and its 200 day moving average price is $313.01.

Cencora (NYSE:COR) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $3.84 earnings per share for the quarter, beating the consensus estimate of $3.79 by $0.05. Cencora had a return on equity of 227.15% and a net margin of 0.48%.The company had revenue of $83.73 billion during the quarter, compared to the consensus estimate of $83.36 billion. During the same period in the previous year, the firm posted $3.34 EPS. Cencora’s revenue was up 5.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.450-17.75 EPS. As a group, sell-side analysts anticipate that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 1st. Shareholders of record on Friday, November 14th were issued a $0.60 dividend. This is a positive change from Cencora’s previous quarterly dividend of $0.55. The ex-dividend date was Friday, November 14th. This represents a $2.40 annualized dividend and a yield of 0.7%. Cencora’s dividend payout ratio (DPR) is presently 30.19%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.